Cargando…
Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy
The RAS-RAF-MEK-ERK signaling pathway (MAPK signaling pathway) plays a significant role in multiple pathological behaviors and is most frequently dysregulated in more than 30% of human cancers. As key elements in this pathway, MEK1/2 play crucial roles in tumorigenesis and the inhibition of apoptosi...
Autores principales: | Li, Yanan, Dong, Qingrong, Cui, Yukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743629/ https://www.ncbi.nlm.nih.gov/pubmed/31565475 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0137 |
Ejemplares similares
-
Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems
por: Nagaria, Teddy S., et al.
Publicado: (2017) -
MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions
por: Harder, Anja
Publicado: (2021) -
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
por: Haagensen, E J, et al.
Publicado: (2012) -
Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells
por: Arafeh, Rand, et al.
Publicado: (2017) -
A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1
por: Li, Yanan, et al.
Publicado: (2020)